OBJECTIVES: In developing countries, where mother-to-child transmission of HIV through breast-feeding is common, little is known about the impact of postpartum transmission on child survival. This study assessed whether children infected postpartum have longer survival from time of infection versus those infected during gestation or delivery. DESIGN: We used a prospective cohort study to analyze data from 213 HIV-infected children enrolled in a breast-feeding intervention trial in Lusaka, Zambia (2001 to 2004). METHODS: We compared mortality 1 year after HIV infection in children stratified by age of infection: 0 to 3 days (intrauterine [IU] group), 4 to 40 days (intrapartum/early postpartum [IP/EPP] group), and >40 days (postpartum [PP] group). RESULTS: A total of 61, 71, and 81 children were infected in the IU, IP/EPP, and PP groups, respectively. Children with intrauterine or intrapartum/early postpartum transmission had higher mortality over the first 12 months after infection than children with postpartum transmission (P = 0.001 and P = 0.006, respectively); no differences were detected between children with intrauterine and intrapartum/early postpartum transmission. Nearly 20% of the IU and IP/EPP groups died by 100 days after infection, whereas nearly 10% of the PP group had died by this time. After adjusting for birth weight, maternal CD4 cell count, breast-feeding, and maternal death, children infected postpartum had one quarter the mortality rate (hazard ratio [HR] = 0.27, 95% confidence interval [CI]: 0.15 to 0.50) of those infected in utero. Stopping breast-feeding increased mortality in infected children (HR = 3.1, 95% CI: 1.8 to 5.3). CONCLUSIONS: This study demonstrates a survival benefit among children infected postpartum versus children infected during pregnancy or delivery and a benefit to increased breast-feeding duration among infected children. Testing children for HIV early may provide a means to allow for earlier intervention.
OBJECTIVES: In developing countries, where mother-to-child transmission of HIV through breast-feeding is common, little is known about the impact of postpartum transmission on child survival. This study assessed whether children infected postpartum have longer survival from time of infection versus those infected during gestation or delivery. DESIGN: We used a prospective cohort study to analyze data from 213 HIV-infectedchildren enrolled in a breast-feeding intervention trial in Lusaka, Zambia (2001 to 2004). METHODS: We compared mortality 1 year after HIV infection in children stratified by age of infection: 0 to 3 days (intrauterine [IU] group), 4 to 40 days (intrapartum/early postpartum [IP/EPP] group), and >40 days (postpartum [PP] group). RESULTS: A total of 61, 71, and 81 children were infected in the IU, IP/EPP, and PP groups, respectively. Children with intrauterine or intrapartum/early postpartum transmission had higher mortality over the first 12 months after infection than children with postpartum transmission (P = 0.001 and P = 0.006, respectively); no differences were detected between children with intrauterine and intrapartum/early postpartum transmission. Nearly 20% of the IU and IP/EPP groups died by 100 days after infection, whereas nearly 10% of the PP group had died by this time. After adjusting for birth weight, maternal CD4 cell count, breast-feeding, and maternal death, children infected postpartum had one quarter the mortality rate (hazard ratio [HR] = 0.27, 95% confidence interval [CI]: 0.15 to 0.50) of those infected in utero. Stopping breast-feeding increased mortality in infected children (HR = 3.1, 95% CI: 1.8 to 5.3). CONCLUSIONS: This study demonstrates a survival benefit among children infected postpartum versus children infected during pregnancy or delivery and a benefit to increased breast-feeding duration among infected children. Testing children for HIV early may provide a means to allow for earlier intervention.
Authors: R Nduati; G John; D Mbori-Ngacha; B Richardson; J Overbaugh; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Hughes; J Kreiss Journal: JAMA Date: 2000-03-01 Impact factor: 56.272
Authors: K M De Cock; M G Fowler; E Mercier; I de Vincenzi; J Saba; E Hoff; D J Alnwick; M Rogers; N Shaffer Journal: JAMA Date: 2000-03-01 Impact factor: 56.272
Authors: Lynn S Zijenah; Lawrence H Moulton; Peter Iliff; Kusum Nathoo; Marshall W Munjoma; Kuda Mutasa; Lucie Malaba; Parteson Zvandasara; Brian J Ward; Jean Humphrey Journal: AIDS Date: 2004-01-23 Impact factor: 4.177
Authors: Anna Coutsoudis; Francois Dabis; Wafaie Fawzi; Philippe Gaillard; Geert Haverkamp; D Robert Harris; J Brooks Jackson; Valerie Leroy; Nicolas Meda; Philippe Msellati; Marie-Louise Newell; Ruth Nsuati; Jennifer S Read; Stefan Wiktor Journal: J Infect Dis Date: 2004-05-26 Impact factor: 5.226
Authors: Belinda L Herring; Ying C Ge; Bin Wang; Mala Ratnamohan; Frank Zheng; Anthony L Cunningham; Nitin K Saksena; Dominic E Dwyer Journal: J Clin Microbiol Date: 2003-10 Impact factor: 5.948
Authors: Rebecca R Gray; Marco Salemi; Amanda Lowe; Kyle J Nakamura; William D Decker; Moses Sinkala; Chipepo Kankasa; Connie J Mulligan; Donald M Thea; Louise Kuhn; Grace Aldrovandi; Maureen M Goodenow Journal: AIDS Date: 2011-01-14 Impact factor: 4.177
Authors: Rebecca M Zash; Roger L Shapiro; Jean Leidner; Carolyn Wester; Alexander J McAdam; Richard L Hodinka; Ibou Thior; Claire Moffat; Joseph Makhema; Kenneth McIntosh; Max Essex; Shahin Lockman Journal: Paediatr Int Child Health Date: 2016-08 Impact factor: 1.990
Authors: Kartik K Venkatesh; Guy de Bruyn; Edmore Marinda; Kennedy Otwombe; Ronelle van Niekerk; Michael Urban; Elizabeth W Triche; Stephen T McGarvey; Mark N Lurie; Glenda E Gray Journal: J Trop Pediatr Date: 2010-07-03 Impact factor: 1.165
Authors: Kristjana H Ásbjörnsdóttir; Jennifer A Slyker; Noel S Weiss; Dorothy Mbori-Ngacha; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Grace John-Stewart Journal: AIDS Date: 2013-11-13 Impact factor: 4.177
Authors: Sallie R Permar; Maria G Salazar; Feng Gao; Fangping Cai; Gerald H Learn; Linda Kalilani; Beatrice H Hahn; George M Shaw; Jesus F Salazar-Gonzalez Journal: Retrovirology Date: 2013-08-14 Impact factor: 4.602